About
Microbiome Skin Treatments
Areas of Focus
Categories
Biologics & BiopharmaceuticalMicrobiomeBoston & New England
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
65
By Phase
PHASE1/PHASE2: 2PHASE1: 1NA: 1
By Status
RECRUITING: 2WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06830863Lead Sponsor
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
PHASE1/PHASE2Recruiting
32 participants
Started: Aug 25, 2025 · Completed: May 15, 2026
NCT06137157Lead Sponsor
Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
PHASE1Recruiting
12 participants
Started: Jun 19, 2024 · Completed: Apr 1, 2026
NCT04731259Lead Sponsor
Study to Evaluate the Safety of ATR-04
PHASE1/PHASE2Withdrawn
Started: Jan 31, 2024 · Completed: Jan 31, 2026
NCT03820076Lead Sponsor
Safety Study of AZT-04 for Cosmetic Use
NACompleted
21 participants
Started: Jan 17, 2019 · Completed: Jul 31, 2019
Locations (1)
Headquarters
Branford, CT, United States
Map
Loading map...